Award

(NU/1433-11) GlycoScore: Commercialisation of university research through provision of management skills to assist in successful spin-out company creation

NEWCASTLE UNIVERSITY

This public procurement record has 1 release in its history.

Award

26 Jun 2020 at 09:54

Award Notice
Summary of the contracting process

The procurement process initiated by Newcastle University revolves around the project titled "(NU/1433-11) GlycoScore: Commercialisation of university research through provision of management skills to assist in successful spin-out company creation." This tender falls within the business and management consultancy services category and is located in Newcastle, England. The procurement method utilized is classified as 'Other,' and the current stage is 'Award,' following the completion of the tender period on 15 May 2020. The awarded contract is valued at £30,000 and runs from 26 June 2020 to 30 October 2020. Key contact for this opportunity is Natalie Morton, reachable at +44 1912086396 or via email at natalie.morton@ncl.ac.uk.

This tender represents an excellent opportunity for small and medium-sized enterprises (SMEs) specialising in business consultancy, particularly those with experience in developing business plans and managing spin-out companies. Businesses that can provide expertise in securing venture capital funding and have experience in the healthcare or diagnostics industry would be particularly well-suited to compete. Engaging in this project could provide a valuable entry point for SMEs to establish partnerships with a reputable educational institution and contribute to the advancement of innovative diagnostic solutions for prostate cancer.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Start Free Trial Book a Demo
All Features Pricing

Notice Information

Notice Title

(NU/1433-11) GlycoScore: Commercialisation of university research through provision of management skills to assist in successful spin-out company creation

Notice Description

Prostate cancer is the most common cancer in men in the UK. It develops slowly and can go undetected for many years. It has been estimated that the annual economic burden of the disease in the UK exceeds PS269 million. This cost is expected to increase due to the rising prevalence of the disease, attributed to an ageing population. Current diagnosis relies on a combination of prostate-specific antigen (PSA) testing (which has low specificity and no prognostic value), and tissue biopsies (which are expensive, can be painful and only provide a snapshot of the tumour). A major problem is the difficulty distinguishing indolent benign (benign prostate hyperplasia (BHP)) and aggressive tumours. This leads to over-diagnosis, resulting in unnecessary biopsies, but also means some aggressive cancers are missed. The Newcastle University team have developed a simple in-vitro diagnostic (IVD) that looks for 3 protein biomarkers. This diagnostic test 'GlycoScore' is based on a simple protein detection method (ELISA), using patient blood, which is widely used in clinics across the world, increasing the chances of adoption. Importantly, we have demonstrated that our diagnostic is superior to the current PSA blood test. Analysis comparing benign prostate hyperplasia (BPH) and prostate cancer showed the GlycoScore had a positive predictive value (PPV) of 93%, whereas PSA had a PPV of 68%. The team has strong links with clinicians and patient groups and has been working with these stakeholders to better understand the current care pathway and how GlycoScore could be best implemented in a clinical environment. The initial brief of the executive will be to: (1) Produce a viable 5 year business plan; (2) Obtain university approval for the venture; (3) a. Act for the company in the spin-out legal process and address all company formation matters; b. Obtain founder academics' and Newcastle University (including the Head of Company Creation) approval for appointment as CEO. c. Provide to the appropriate university all matters necessary for ERDF or Research England reporting requirements; (4) Secure (venture capital and other) funding

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-b5fd17-7607808c-b705-4434-a6ac-a18545694d40
Publication Source
Contracts Finder
Latest Notice
https://www.contractsfinder.service.gov.uk/Notice/aeefdc36-2085-400e-87c9-5aeeb079c478
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Standard
Procurement Category
Services
Procurement Method
Not Specified
Procurement Method Details
Other -
Tender Suitability
SME
Awardee Scale
SME

Common Procurement Vocabulary (CPV)

CPV Divisions

79 - Business services: law, marketing, consulting, recruitment, printing and security

CPV Codes

79400000 - Business and management consultancy and related services

Notice Value(s)

Tender Value
£30,000 Under £100K
Lots Value
Not specified
Awards Value
£30,000 Under £100K
Contracts Value
Not specified

Notice Dates

Publication Date
26 Jun 20205 years ago
Submission Deadline
15 May 2020Expired
Future Notice Date
Not specified
Award Date
23 Jun 20205 years ago
Contract Period
25 Jun 2020 - 30 Oct 2020 1-6 months
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Not Specified
Awards Status
Active
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NEWCASTLE UNIVERSITY
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
NEWCASTLE
Postcode
NE1 7RU
Post Town
Newcastle upon Tyne
Country
England
Major Region (ITL 1)
TLC North East (England)
Basic Region (ITL 2)
TLC4 Northumberland, Durham and Tyne & Wear
Small Region (ITL 3)
TLC43 Tyneside
Delivery Location
Not specified
Local Authority
Newcastle upon Tyne
Electoral Ward
Monument
Westminster Constituency
Newcastle upon Tyne Central and West

Supplier Information

Number of Suppliers
1
Supplier Name

MR ALLAN BROWN

Further Information

Notice Documents

Notice URLs

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts. 

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-b5fd17-7607808c-b705-4434-a6ac-a18545694d40-2020-06-26T10:54:04+01:00",
    "date": "2020-06-26T10:54:04+01:00",
    "ocid": "ocds-b5fd17-7607808c-b705-4434-a6ac-a18545694d40",
    "language": "en",
    "initiationType": "tender",
    "tender": {
        "id": "NCL001-DN475582-47398704",
        "title": "(NU/1433-11) GlycoScore: Commercialisation of university research through provision of management skills to assist in successful spin-out company creation",
        "description": "Prostate cancer is the most common cancer in men in the UK. It develops slowly and can go undetected for many years. It has been estimated that the annual economic burden of the disease in the UK exceeds PS269 million. This cost is expected to increase due to the rising prevalence of the disease, attributed to an ageing population. Current diagnosis relies on a combination of prostate-specific antigen (PSA) testing (which has low specificity and no prognostic value), and tissue biopsies (which are expensive, can be painful and only provide a snapshot of the tumour). A major problem is the difficulty distinguishing indolent benign (benign prostate hyperplasia (BHP)) and aggressive tumours. This leads to over-diagnosis, resulting in unnecessary biopsies, but also means some aggressive cancers are missed. The Newcastle University team have developed a simple in-vitro diagnostic (IVD) that looks for 3 protein biomarkers. This diagnostic test 'GlycoScore' is based on a simple protein detection method (ELISA), using patient blood, which is widely used in clinics across the world, increasing the chances of adoption. Importantly, we have demonstrated that our diagnostic is superior to the current PSA blood test. Analysis comparing benign prostate hyperplasia (BPH) and prostate cancer showed the GlycoScore had a positive predictive value (PPV) of 93%, whereas PSA had a PPV of 68%. The team has strong links with clinicians and patient groups and has been working with these stakeholders to better understand the current care pathway and how GlycoScore could be best implemented in a clinical environment. The initial brief of the executive will be to: (1) Produce a viable 5 year business plan; (2) Obtain university approval for the venture; (3) a. Act for the company in the spin-out legal process and address all company formation matters; b. Obtain founder academics' and Newcastle University (including the Head of Company Creation) approval for appointment as CEO. c. Provide to the appropriate university all matters necessary for ERDF or Research England reporting requirements; (4) Secure (venture capital and other) funding",
        "status": "complete",
        "classification": {
            "scheme": "CPV",
            "id": "79400000",
            "description": "Business and management consultancy and related services"
        },
        "items": [
            {
                "id": "1",
                "deliveryAddresses": [
                    {
                        "countryName": "United Kingdom"
                    }
                ]
            }
        ],
        "value": {
            "amount": 30000,
            "currency": "GBP"
        },
        "procurementMethodDetails": "Other -",
        "tenderPeriod": {
            "endDate": "2020-05-15T23:59:59+01:00"
        },
        "contractPeriod": {
            "startDate": "2020-06-27T00:00:00+01:00",
            "endDate": "2020-10-30T23:59:59Z"
        },
        "suitability": {
            "sme": true,
            "vcse": false
        },
        "mainProcurementCategory": "services"
    },
    "parties": [
        {
            "id": "GB-CFS-51687",
            "name": "Newcastle University",
            "identifier": {
                "legalName": "Newcastle University"
            },
            "address": {
                "streetAddress": "Newcastle University, Procurement Services, Kingsgate",
                "locality": "Newcastle",
                "postalCode": "NE1 7RU",
                "countryName": "England"
            },
            "contactPoint": {
                "name": "Natalie Morton",
                "email": "natalie.morton@ncl.ac.uk",
                "telephone": "+44 1912086396"
            },
            "details": {
                "url": "https://ncl.ac.uk"
            },
            "roles": [
                "buyer"
            ]
        },
        {
            "id": "GB-CFS-146233",
            "name": "Mr Allan Brown",
            "identifier": {
                "legalName": "Mr Allan Brown"
            },
            "address": {
                "streetAddress": "White Cottage, Boots Green Lane Allostock Cheshire WA16 9NH"
            },
            "details": {
                "scale": "sme",
                "vcse": false
            },
            "roles": [
                "supplier"
            ]
        }
    ],
    "buyer": {
        "id": "GB-CFS-51687",
        "name": "Newcastle University"
    },
    "awards": [
        {
            "id": "ocds-b5fd17-7607808c-b705-4434-a6ac-a18545694d40-1",
            "status": "active",
            "date": "2020-06-24T00:00:00+01:00",
            "datePublished": "2020-06-26T10:54:04+01:00",
            "value": {
                "amount": 30000,
                "currency": "GBP"
            },
            "suppliers": [
                {
                    "id": "GB-CFS-146233",
                    "name": "Mr Allan Brown"
                }
            ],
            "contractPeriod": {
                "startDate": "2020-06-26T00:00:00+01:00",
                "endDate": "2020-10-30T23:59:59Z"
            },
            "documents": [
                {
                    "id": "1",
                    "documentType": "awardNotice",
                    "description": "Awarded contract notice on Contracts Finder",
                    "url": "https://www.contractsfinder.service.gov.uk/Notice/aeefdc36-2085-400e-87c9-5aeeb079c478",
                    "datePublished": "2020-06-26T10:54:04+01:00",
                    "format": "text/html",
                    "language": "en"
                }
            ]
        }
    ]
}